We are live on
!
Find out more
Lord, Abbett & Co Portfolio holdings
AUM
$30.6B
1-Year Est. Return
57.44%
This Fund
S&P 500
This Quarter
Est. Return
-11.95%
1 Year Est. Return
+57.44%
3 Year Est. Return
+215.76%
5 Year Est. Return
+368.6%
10 Year Est. Return
+2,376.62%
AUM
$28.3B
AUM Growth
-$9.23B
(-25%)
Cap. Flow
-$5.59B
Cap. Flow
% of AUM
-19.76%
Top 10 Holdings %
Top 10 Hldgs %
17.15%
Holding
651
New
62
Increased
201
Reduced
214
Closed
94
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elevance Health
ELV
|
+$97.8M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$95.6M |
| 3 |
Cheniere Energy
LNG
|
+$94.4M |
| 4 |
Visa
V
|
+$92.5M |
| 5 |
AstraZeneca
AZN
|
+$88.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SBNY
Signature Bank
SBNY
|
+$204M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$196M |
| 3 |
NVIDIA
NVDA
|
+$131M |
| 4 |
Alexandria Real Estate Equities
ARE
|
+$130M |
| 5 |
Marathon Petroleum
MPC
|
+$129M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.41% |
| 2 | Healthcare | 17.34% |
| 3 | Financials | 13.09% |
| 4 | Industrials | 10.79% |
| 5 | Consumer Discretionary | 7.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Ultragenyx Pharmaceutical
RARE
$2.46B
| $19.4M | 0.07% |
324,724
+10,980
| +3% | +$676K |
|
302
Crocs
CROX
$6.63B
| $19.1M | 0.07% |
391,753
+13,153
| +3% | +$798K |
|
303
Sprout Social
SPT
$530M
| $18.6M | 0.07% |
320,131
-319,154
| -50% | -$18.5M |
|
304
TSMC
TSM
$1.94T
| $18.3M | 0.06% |
223,333
-62,134
| -22% | -$5.75M |
|
305
International Money Express
IMXI
$389M
| $16.9M | 0.06% |
823,519
-161,300
| -16% | -$3.23M |
|
306
Nexstar Media Group
NXST
$6.01B
| $16.8M | 0.06% |
103,430
-116,330
| -53% | -$19.6M |
|
307
Simpson Manufacturing
SSD
$7.79B
| $16.8M | 0.06% |
166,832
-39,636
| -19% | -$4.12M |
|
308
Teradyne
TER
$50B
| $16.4M | 0.06% |
183,340
+2,590
| +1% | +$269K |
|
309
TransDigm Group
TDG
$70.7B
| $16M | 0.06% |
29,880
+2,559
| +9% | +$1.51M |
|
310
Corteva
CTVA
$60.5B
| $16M | 0.06% |
295,040
-82,217
| -22% | -$4.77M |
|
311
Flywire
FLYW
$2.04B
| $15.8M | 0.06% |
894,429
+530,046
| +145% | +$12.3M |
|
312
Paylocity
PCTY
$7.75B
| $15.5M | 0.05% |
88,727
+20,656
| +30% | +$3.76M |
|
313
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.68B
| $15.4M | 0.05% |
12,666
-640
| -5% | -$787K |
|
314
TJX Companies
TJX
$179B
| $15.3M | 0.05% |
273,600
-300
| -0.1% | -$18.2K |
|
315
Amphenol
APH
$185B
| $15.2M | 0.05% |
472,176
-2,986,654
| -86% | -$104M |
|
316
Halozyme
HALO
$9.88B
| $15M | 0.05% |
+340,686
| New | +$14.7M |
|
|
ESTE
317
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
| $14.4M | 0.05% |
+1,058,094
| New | +$16.6M |
|
|
IAS
318
DELISTED
Integral Ad Science
IAS
| $14.2M | 0.05% |
1,432,981
+48,419
| +3% | +$578K |
|
319
Dave & Buster's
PLAY
$357M
| $14.2M | 0.05% |
432,687
+292,687
| +209% | +$11.7M |
|
320
Chefs' Warehouse
CHEF
$4.31B
| $14.2M | 0.05% |
364,048
+105,163
| +41% | +$3.69M |
|
321
United Parks & Resorts
PRKS
$2.19B
| $14M | 0.05% |
316,643
+119,457
| +61% | +$6.94M |
|
322
DexCom
DXCM
$29B
| $13.9M | 0.05% |
186,555
+11,111
| +6% | +$1.01M |
|
323
Agilysys
AGYS
$3.21B
| $13.7M | 0.05% |
290,816
+92,363
| +47% | +$3.6M |
|
324
Impinj
PI
$4.24B
| $13.1M | 0.05% |
224,050
+15,211
| +7% | +$764K |
|
325
Bank of America Series L
BAC.PRL
$3.93B
| $12.9M | 0.05% |
10,740
-830
| -7% | -$1.02M |
|
Similar funds
Lord, Abbett & Co's Q2 2022 Portfolio in Review
As of Q2 2022, Lord, Abbett & Co held 651 positions worth $28.3B, down 25% from $37.5B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Lord, Abbett & Co withdrew a net $5.59B in Q2 2022, closing 94 positions and reducing 214 holdings. Its most notable exit was Signature Bank, an estimated $204M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Lord, Abbett & Co opened a new position in Elevance Health worth $95.4M.
- Lord, Abbett & Co's largest Q2 2022 buy was Elevance Health: 197,668 shares worth $95.4M.
- Lord, Abbett & Co added most to Seagen Inc. Common Stock in Q2 2022, an estimated $95.6M increase.
- Lord, Abbett & Co's biggest Q2 2022 reduction was Alphabet (Google) Class A, cutting an estimated $196M.
- Lord, Abbett & Co fully exited Signature Bank in Q2 2022, selling an estimated $204M.
- Lord, Abbett & Co's ten largest holdings make up 17% of its $28.3B portfolio in Q2 2022.
- Lord, Abbett & Co opened 62 new positions and closed 94 in Q2 2022.
- Lord, Abbett & Co's portfolio value fell 25% quarter-over-quarter to $28.3B.
Based on Lord, Abbett & Co's 13F filing for Q2 2022, filed 12 Aug 2022.